Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
SNDK
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
1701
Dynex Capital
DX
$3.23B
| $8.13M | ﹤0.01% |
619,846
+270,379
| +77% | +$3.56M |
|
|
CHCT
1702
Community Healthcare Trust
CHCT
$426M
| $8.11M | ﹤0.01% |
443,896
+138,066
| +45% | +$2.4M |
|
1703
Orthofix Medical
OFIX
$408M
| $8.11M | ﹤0.01% |
887,282
+698,158
| +369% | +$7.7M |
|
1704
Aspen Aerogels
ASPN
$430M
| $8.09M | ﹤0.01% |
1,276,346
+750,227
| +143% | +$3.68M |
|
|
QXO
1705
QXO Inc
QXO
$14.3B
| $8.07M | ﹤0.01% |
467,279
-48,246
| -9% | -$898K |
|
1706
American Superconductor
AMSC
$1.45B
| $8.07M | ﹤0.01% |
194,477
+9,722
| +5% | +$440K |
|
1707
Vanguard FTSE Europe ETF
VGK
$31.2B
| $8.06M | ﹤0.01% |
91,047
+41,903
| +85% | +$3.67M |
|
1708
VanEck Gold Miners ETF
GDX
$32B
| $8.06M | ﹤0.01% |
106,785
+5,899
| +6% | +$521K |
|
1709
Tandem Diabetes Care
TNDM
$1.55B
| $8.06M | ﹤0.01% |
533,837
+201,921
| +61% | +$3.53M |
|
1710
First Internet Bancorp
INBK
$255M
| $8.05M | ﹤0.01% |
289,641
+214,463
| +285% | +$5.2M |
|
1711
PennyMac Financial
PFSI
$3.9B
| $8.03M | ﹤0.01% |
92,167
+41,193
| +81% | +$3.58M |
|
1712
Dr. Reddy's Laboratories
RDY
$10.1B
| $8.01M | ﹤0.01% |
552,705
+107,428
| +24% | +$1.45M |
|
1713
Aldeyra Therapeutics
ALDX
$91.7M
| $7.99M | ﹤0.01% |
3,751,558
+921,683
| +33% | +$1.58M |
|
1714
Pricesmart
PSMT
$5.33B
| $7.98M | ﹤0.01% |
40,826
+3,093
| +8% | +$516K |
|
1715
ESCO Technologies
ESE
$7.44B
| $7.96M | ﹤0.01% |
22,731
+49
| +0.2% | +$15.3K |
|
1716
AdaptHealth
AHCO
$751M
| $7.94M | ﹤0.01% |
761,857
-204,562
| -21% | -$2.28M |
|
1717
Primoris Services
PRIM
$4.15B
| $7.93M | ﹤0.01% |
80,022
-32,032
| -29% | -$4.21M |
|
1718
Mercantile Bank Corp
MBWM
$1.03B
| $7.91M | ﹤0.01% |
137,726
-8,987
| -6% | -$474K |
|
1719
Summit Therapeutics
SMMT
$10.5B
| $7.9M | ﹤0.01% |
542,178
+98,421
| +22% | +$1.75M |
|
1720
LXP Industrial Trust
LXP
$3.59B
| $7.9M | ﹤0.01% |
146,598
+6,466
| +5% | +$333K |
|
1721
Albany International
AIN
$1.68B
| $7.89M | ﹤0.01% |
105,902
+68,460
| +183% | +$4.29M |
|
1722
Viking Therapeutics
VKTX
$3.95B
| $7.84M | ﹤0.01% |
200,958
+188,786
| +1,551% | +$6.1M |
|
|
SEI
1723
Solaris Energy Infrastructure
SEI
$3.51B
| $7.84M | ﹤0.01% |
97,399
-67
| -0.1% | -$4.79K |
|
1724
Xencor
XNCR
$2.07B
| $7.79M | ﹤0.01% |
483,834
+321,419
| +198% | +$4.01M |
|
1725
Adaptive Biotechnologies
ADPT
$4.15B
| $7.78M | ﹤0.01% |
362,916
-122,317
| -25% | -$1.87M |
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.